Consideration of competing risks in early setting in oncology and impact on the survival estimates: to explicitly model them? An example of a french real-world cohort in urothelial carcinoma
Langue
EN
Communication dans un congrès
Ce document a été publié dans
Value in Health, ISPOR Europe 2023, 2023-11-11, Copenhague. 2023-12-01, vol. 26, n° 12 suppl., p. S419
Résumé en anglais
In early-stage cancers, tumor resection may be followed by local recurrence (LR), distant metastases (DM), or death. When investigating DM-free survival, LR is a competing event (CE) as it modifies the risk of DM. We ...Lire la suite >
In early-stage cancers, tumor resection may be followed by local recurrence (LR), distant metastases (DM), or death. When investigating DM-free survival, LR is a competing event (CE) as it modifies the risk of DM. We assessed DM-free survival according to 3 methods: the “Include” method (properly accounts for CE), as well as two simple but less optimal strategies, “Ignore” and “Censor”.< Réduire
Unités de recherche